Oxygen Therapy for Patients with Acute Myocardial Infarction
Benefits in NNT
Harms in NNT
No harms reported
No harms reported
SourceSepehrvand N, James SK, Stub D, Khoshnood A, Ezekowitz JA, Hofmann R. Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials. Heart. 2018;104:1691-1698.
Study Population: Roughly 8000 subjects experiencing a heart attack
Efficacy EndpointsMortality, subsequent heart failure
Harm EndpointsNot assessed
NarrativeMyocardial infarction (MI), or heart attack, is the death or injury of heart muscle when blood flow is abruptly cut off, and is a leading cause of death internationally with approximately 1.5 million cases per year in the United States.1 Supplemental oxygen in patients with MI (regardless of baseline oxygen level) is often used to improve oxygen supply to heart muscle, in hopes of reducing cardiac damage and thus improving outcomes.2, 3, 4
The systematic review discussed here, including nearly 8000 subjects from 8 randomized trials,5 is dominated by a single nationwide registry trial of 6629 subjects in Sweden.6 In this study, patients with suspected myocardial infarction (based on either ischemic electrocardiographic or blood troponin changes) and normal oxygen saturation were randomly assigned to receive either supplemental oxygen by face mask for 6-12 hours or ambient air, in a non-blinded fashion.6 Oxygen therapy did not reduce death or any other endpoint measured at 2.1 years, and no subgroups were differentially benefited or harmed.6 These findings echoed the systematic review.5
CaveatsThe main limitation of these data is inherent to the design of large registry trials like the Swedish one reported here. Registry trials are often pragmatic, eschewing steps such as blinding, and other features designed to minimize variation and bias. However, such trials have the advantage of being performed in ways that are consistent with usual practice, suggesting their results will translate more easily when implemented. The investigators in the Swedish trial did attempt to limit biases by, for instance, blinding outcome assessors to group assignments, and it is reassuring that the findings of 7 other trials included with in the systematic review5 are consistent with this large study. However, it remains feasible that methodologically more rigorous studies could find small outcome differences not detected in these data.
In conclusion, existing evidence does not support routine supplemental oxygen for patients with acute myocardial infarction. Therefore, we have assigned a color recommendation of Red (No Benefit) to this intervention.
AuthorJia Jian Li, MDSupervising editors: Shahriar Zehtabchi, MD
Published/UpdatedFebruary 1, 2019
GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–1544.
Kelly RF, Hursey TL, Parrillo JE, Schaer GL. Effect of 100% oxygen administration on infarct size and left ventricular function in a canine model of myocardial infarction and reperfusion. Am Heart J. 1995;130:957–965.
Madias JE, Madias NE, Hood WB Jr. Precordial ST-segment mapping. 2. Effects of oxygen inhalation on ischemic injury in patients with acute myocardial infarction. Circulation. 1976;53:411–417.
Maroko PR, Radvany P, Braunwald E, Hale SL. Reduction of infarct size by oxygen inhalation following acute coronary occlusion. Circulation. 1975;52:360–368.
Sepehrvand N, James SK, Stub D, Khoshnood A, Ezekowitz JA, Hofmann R. Effects of supplemental oxygen therapy in patients with suspected acute myocardial infarction: a meta-analysis of randomised clinical trials. Heart. 2018;104:1691-1698.